Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Nissha Co., Ltd.

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$5B
Portfolio companies 5
Rounds per year 0.07
Lead investments 0
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Manufacturing
  • Neuroscience
  • Medical
Summary

Nissha Co., Ltd. appeared to be the Corporate Investor, which was created in 1946. The company was established in North America in United States. The main department of described Corporate Investor is located in the Geneva.

The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Nissha Co., Ltd. works on 4 percentage points more the average amount of lead investments. The high activity for fund was in 2017.

Among the most popular portfolio startups of the fund, we may highlight Sky Medical Technology, C3Nano. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Software, Printing. The fund has specific favorite in a number of founders of portfolio startups.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the Nissha Co., Ltd., startups are often financed by GSR Ventures, Phoenix Venture Partners LLC, Juno Capital Partners. The meaningful sponsors for the fund in investment in the same round are Sony, Innovation Network Corporation of Japan, Xinjiang Guoli Minsheng Equity Investment. In the next rounds fund is usually obtained by Barvest Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Nissha Co., Ltd.:
Typical Co-investors
Nissha Co., Ltd. is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Nissha Co., Ltd.:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AVIT China, Futian, Guangdong
Chaifetz Group Chicago, Illinois, United States
China Fellow Partners Beijing, Beijing, China
Cultivian Sandbox Ventures Chicago, Illinois, United States
Digital Assets Deployment Community of Madrid, Madrid, Spain
James Dyson Foundation Chicago, Illinois, United States
Kaisheng Shidai Beijing, Beijing, China
KF Ventures Guadalajara, Jalisco, Mexico
North Summit Capital China, Guangdong, Shenzhen
Obotritia Capital Brandenburg, Germany, Potsdam
Power Integrations California, San Jose, United States
Red Maple Ventures Arkansas, United States, Wynne
Riverstone Holdings New York, New York, United States
Shanghai Cheering Capital China, Shanghai
Songhyun Investment -
SWK Funding -
The Paradise Group -
Trust Ventures Austin, Texas, United States
Venmo New York, New York, United States
Vital Capital Switzerland, Zürich, Zurich

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Nanotis

Biotechnology
Health Care
Health Diagnostics
Nursing and Residential Care
$182K15 Apr 2021 Chiyoda, Japan

Sky Medical Technology

Biotechnology
Health Care
Medical
Neuroscience
$13M01 Sep 2017 England

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Nissha Co., Ltd.?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 5B
Rounds per year 0.07
Peak activity year 2017
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Nanotis

Biotechnology
Health Care
Health Diagnostics
Nursing and Residential Care
$182K15 Apr 2021 Chiyoda, Japan

Sky Medical Technology

Biotechnology
Health Care
Medical
Neuroscience
$13M01 Sep 2017 England
Crunchbase icon

Content report

The following text will be sent to our editors: